Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$306.88 - $380.0 $682,501 - $845,120
2,224 Added 0.71%
315,129 $119 Million
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $7.48 Million - $9.41 Million
23,673 Added 8.18%
312,905 $99.5 Million
Q2 2023

Aug 15, 2023

SELL
$346.15 - $392.09 $12 Million - $13.6 Million
-34,801 Reduced 10.74%
289,232 $111 Million
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $1.52 Million - $1.76 Million
4,708 Added 1.47%
324,033 $121 Million
Q4 2022

Feb 13, 2023

BUY
$248.67 - $334.17 $7.16 Million - $9.63 Million
28,812 Added 9.92%
319,325 $106 Million
Q3 2022

Nov 14, 2022

SELL
$263.81 - $337.27 $896,690 - $1.15 Million
-3,399 Reduced 1.16%
290,513 $76.7 Million
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $5.45 Million - $7.75 Million
-18,088 Reduced 5.8%
293,912 $92 Million
Q1 2022

May 16, 2022

BUY
$379.46 - $424.54 $35 Million - $39.1 Million
92,167 Added 41.93%
312,000 $130 Million
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $8.59 Million - $9.98 Million
-22,994 Reduced 9.47%
219,833 $92.1 Million
Q3 2021

Nov 15, 2021

BUY
$396.76 - $455.92 $5.93 Million - $6.82 Million
14,954 Added 6.56%
242,827 $100 Million
Q2 2021

Aug 16, 2021

SELL
$372.36 - $412.07 $29.2 Million - $32.3 Million
-78,313 Reduced 25.58%
227,873 $90.3 Million
Q1 2021

May 13, 2021

BUY
$357.26 - $392.57 $1.17 Million - $1.28 Million
3,273 Added 1.08%
306,186 $118 Million
Q4 2020

Feb 09, 2021

BUY
$319.05 - $363.32 $8.82 Million - $10 Million
27,643 Added 10.04%
302,913 $110 Million
Q3 2020

Nov 05, 2020

BUY
$280.08 - $347.78 $17.8 Million - $22.1 Million
63,627 Added 30.06%
275,270 $92.8 Million
Q2 2020

Aug 13, 2020

BUY
$270.93 - $320.3 $1.5 Million - $1.77 Million
5,540 Added 2.69%
211,643 $60 Million
Q1 2020

May 14, 2020

BUY
$243.44 - $359.98 $50.2 Million - $74.2 Million
206,103 New
206,103 $56.8 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.